RhythmAnalytics vs EchoSolv AS
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your primary need is comprehensive, automated interpretation of various cardiac arrhythmias from single-lead ECG data. This tool is ideal for clinical settings requiring beat-by-beat analysis, rhythm classification, and detection of conditions like AFib, ventricular arrhythmias, and ectopic beats to support broad cardiac rhythm management.
View RhythmAnalytics →Choose EchoSolv AS if…
Choose EchoSolv AS if your focus is specifically on identifying patients at high risk for severe aortic stenosis through efficient, AI-powered analysis of echocardiogram measurements. This platform is best suited for cardiology practices or cardiothoracic surgery departments seeking to prioritize studies for closer review and enhance the accuracy of sAS detection within existing PACS workflows.
View EchoSolv AS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | EchoSolv AS |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Cloud-based API | Cloud-based |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS is explicitly designed to fit existing clinical workflows, integrating seamlessly with PACS and requiring no EMR integration, which simplifies adoption for clinicians. Its ultra-fast risk detection (under 3 seconds) further enhances efficiency. RhythmAnalytics, while cloud-based and API-driven, implies more integration effort for a direct end-user experience, as its usability is largely dependent on the integrating system.
Clinical Value
TieBoth tools are FDA-cleared and provide significant clinical decision support in cardiology. RhythmAnalytics offers automated interpretation of over 15 types of cardiac arrhythmias from single-lead ECG data, with clinical validation demonstrating high sensitivity and specificity. EchoSolv AS focuses on highly accurate identification of patients at risk for severe aortic stenosis from echocardiogram measurements, also backed by strong clinical validation and a 'second reader' support function.
Pricing & Value
EchoSolv ASBoth tools require contacting the vendor for pricing, so transparency is limited for both. However, EchoSolv AS explicitly states it has a Business Associate Agreement (BAA), which is a critical component for healthcare organizations handling Protected Health Information (PHI). RhythmAnalytics' BAA status is unspecified in the provided facts.
Enterprise Readiness
EchoSolv ASEchoSolv AS demonstrates strong enterprise readiness through its explicit BAA, cloud-based deployment, and design for seamless integration with PACS without requiring EMR integration. This simplifies deployment and adoption within existing hospital IT infrastructures. RhythmAnalytics, while cloud-based and API-driven, may require more internal development resources for full enterprise integration.
Innovation
EchoSolv ASWhile both leverage AI, EchoSolv AS presents a distinct methodological innovation by using 'measurement-based AI' that analyzes numerical echocardiogram measurements rather than images, and specifically notes it 'does not use LVOT measurements' which can be prone to variability. This approach offers a novel way to address a specific clinical challenge. RhythmAnalytics' innovation lies in its comprehensive, automated, and broad-spectrum ECG analysis.
Support & Docs
TieNeither the provided structured facts nor the web searches yielded specific details about dedicated support portals, comprehensive documentation libraries, or explicit service level agreements for either RhythmAnalytics or EchoSolv AS. Both companies generally mention support for their broader platforms.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | EchoSolv AS |
|---|---|---|
| Name | RhythmAnalytics | EchoSolv AS |
| Company | Biofourmis Singapore Pte. | Echo IQ |
| Primary Clinical Focus | Automated interpretation of cardiac arrhythmias from single-lead ECG data | Identify patients at risk for severe aortic stenosis by analyzing echocardiograms |
| AI Input Data Type | Single-lead ECG data | Echocardiogram measurements (numerical measurements, not images) |
| Key Output/Decision Support | AI-based automated interpretation of cardiac arrhythmias; Detection of over 15 types of cardiac arrhythmias; Beat-by-beat morphology computation; ECG signal processing and analysis; QRS and Ventricular Ectopic Beat detection; QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis | AI-powered clinical decision support for severe aortic stenosis probability; Consistent severe AS probability and guideline check from measurements; Second reader support to help prioritize studies for closer review; Ultra-fast risk detection (under 3 seconds) |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Cardiothoracic Surgery |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and EchoSolv AS.